BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28744130)

  • 21. Long noncoding RNA AK126698 inhibits proliferation and migration of non-small cell lung cancer cells by targeting Frizzled-8 and suppressing Wnt/β-catenin signaling pathway.
    Fu X; Li H; Liu C; Hu B; Li T; Wang Y
    Onco Targets Ther; 2016; 9():3815-27. PubMed ID: 27445486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HNF1A/CASC2 regulates pancreatic cancer cell proliferation through PTEN/Akt signaling.
    Yu Y; Liang S; Zhou Y; Li S; Li Y; Liao W
    J Cell Biochem; 2019 Mar; 120(3):2816-2827. PubMed ID: 28865121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
    Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
    Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A long noncoding RNA UCA1 promotes proliferation and predicts poor prognosis in glioma.
    Zhao W; Sun C; Cui Z
    Clin Transl Oncol; 2017 Jun; 19(6):735-741. PubMed ID: 28105536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA LINC01089 predicts clinical prognosis and inhibits cell proliferation and invasion through the Wnt/β-catenin signaling pathway in breast cancer.
    Yuan H; Qin Y; Zeng B; Feng Y; Li Y; Xiang T; Ren G
    Onco Targets Ther; 2019; 12():4883-4895. PubMed ID: 31417284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low microRNA-622 expression predicts poor prognosis and is associated with ZEB2 in glioma.
    Song Q; Pang H; Qi L; Liang C; Wang T; Wang W; Li R
    Onco Targets Ther; 2019; 12():7387-7397. PubMed ID: 31686846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway.
    Gao Y; Lu X
    Tumour Biol; 2016 Feb; 37(2):1461-9. PubMed ID: 26662307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA panel as a molecular biomarker in glioma.
    Ebrahimi AA; Ashoori H; Vahidian F; Mosleh IS; Kamian S
    J Egypt Natl Canc Inst; 2021 Oct; 33(1):31. PubMed ID: 34693506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RIZ1: a potential tumor suppressor in glioma.
    Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
    BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
    Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CACNA2D3 is downregulated in gliomas and functions as a tumor suppressor.
    Jin Y; Cui D; Ren J; Wang K; Zeng T; Gao L
    Mol Carcinog; 2017 Mar; 56(3):945-959. PubMed ID: 27583705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.
    Hu L; Lv QL; Chen SH; Sun B; Qu Q; Cheng L; Guo Y; Zhou HH; Fan L
    Int J Environ Res Public Health; 2016 Apr; 13(4):433. PubMed ID: 27104549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
    Liu M; Gao X; Liu CL
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential of circulating lncRNA CASC2 as a biomarker in reflecting the inflammatory cytokines, multi-organ dysfunction, disease severity, and mortality in sepsis patients.
    Wang R; Zhao J; Wei Q; Wang H; Zhao C; Hu C; Han Y; Hui Z; Yang L; Dai Q; Liu C
    J Clin Lab Anal; 2022 Aug; 36(8):e24569. PubMed ID: 35754113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA BLACAT1 promotes cell proliferation, migration and invasion in cervical cancer through activation of Wnt/β-catenin signaling pathway.
    Wang CH; Li YH; Tian HL; Bao XX; Wang ZM
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3002-3009. PubMed ID: 29863244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7.
    Yue X; Cao D; Lan F; Pan Q; Xia T; Yu H
    Neuro Oncol; 2016 Sep; 18(9):1288-96. PubMed ID: 27006177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway.
    Han GH; Lu KJ; Wang P; Ye J; Ye YY; Huang JX
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3795-3803. PubMed ID: 29949155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value and clinical significance of long noncoding RNA CASC2 in human malignancies: a meta-analysis.
    Cai J; Zuo X; Chen Z; Zhao W; Zhu Y; Zhang Z; Ye X
    Cancer Manag Res; 2018; 10():1403-1412. PubMed ID: 29910638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant gliomas induce and exploit astrocytic mesenchymal-like transition by activating canonical Wnt/β-catenin signaling.
    Lu P; Wang Y; Liu X; Wang H; Zhang X; Wang K; Wang Q; Hu R
    Med Oncol; 2016 Jul; 33(7):66. PubMed ID: 27236327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.